Literature DB >> 21576379

Analysis of agonism and inverse agonism in functional assays with constitutive activity: estimation of orthosteric ligand affinity constants for active and inactive receptor states.

Frederick J Ehlert1, Hinako Suga, Michael T Griffin.   

Abstract

We describe a modification of receptor theory for the estimation of observed affinities (K(obs)) and relative efficacies of orthosteric ligands in functional assays that exhibit constitutive activity. Our theory includes parameters for the fractions of the occupied receptor population in the active (intrinsic efficacy, ε) and inactive (ε(i)) states and analogous parameters for the fractions of the free receptor population in the active (ε(sys)) and inactive (ε(i-sys)) states. The total stimulus represents the summation of the active states of the free and occupied receptor populations. A modified operational model is developed that expresses the response as a logistic function of the total stimulus. This function includes the standard parameters related to affinity and efficacy (K(obs) and τ) as well as a parameter proportional to the activity of the free receptor complex, τ(sys). Two related parameters are proportional to the fraction of the free (τ(i-sys)) and occupied (τ(i)) receptor populations in the inactive state. We show that the estimates of the affinity constants of orthosteric ligands for the active (K(b)) and inactive (K(a)) states of the receptor are equivalent to τK(obs)/τ(sys) and τ(i)K(obs)/τ(i-sys), respectively. We verify our method with computer simulation techniques and apply it to the analysis of M(2) and M(3) muscarinic receptors. Our method is applicable in the analysis of ligand bias in drug discovery programs.

Mesh:

Substances:

Year:  2011        PMID: 21576379      PMCID: PMC3141894          DOI: 10.1124/jpet.111.179309

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

1.  Use of constitutive G protein-coupled receptor activity for drug discovery.

Authors:  G Chen; J Way; S Armour; C Watson; K Queen; C K Jayawickreme; W J Chen; T Kenakin
Journal:  Mol Pharmacol       Date:  2000-01       Impact factor: 4.436

Review 2.  Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors.

Authors:  Roland Seifert; Katharina Wenzel-Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2002-09-06       Impact factor: 3.000

3.  Pharmacology of muscarinic receptor subtypes constitutively activated by G proteins.

Authors:  E S Burstein; T A Spalding; M R Brann
Journal:  Mol Pharmacol       Date:  1997-02       Impact factor: 4.436

4.  Spontaneous activity of guinea pig ileum longitudinal muscle regulated by Ca(2+)-activated K+ channel.

Authors:  S J Hong; Y F Roan; C C Chang
Journal:  Am J Physiol       Date:  1997-05

5.  Perfection of a synaptic receptor: kinetics and energetics of the acetylcholine receptor.

Authors:  M B Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  Operational models of pharmacological agonism.

Authors:  J W Black; P Leff
Journal:  Proc R Soc Lond B Biol Sci       Date:  1983-12-22

7.  Transducin activation by the bovine opsin apoprotein.

Authors:  A Surya; K W Foster; B E Knox
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

8.  Specificity of receptor-G protein interactions. Discrimination of Gi subtypes by the D2 dopamine receptor in a reconstituted system.

Authors:  S E Senogles; A M Spiegel; E Padrell; R Iyengar; M G Caron
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

9.  Constitutive receptor systems for drug discovery.

Authors:  G Chen; C Jayawickreme; J Way; S Armour; K Queen; C Watson; D Ignar; W J Chen; T Kenakin
Journal:  J Pharmacol Toxicol Methods       Date:  1999-12       Impact factor: 1.950

10.  Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate.

Authors:  D Colquhoun; B Sakmann
Journal:  J Physiol       Date:  1985-12       Impact factor: 5.182

View more
  11 in total

1.  Quantifying agonist activity at G protein-coupled receptors.

Authors:  Frederick J Ehlert; Hinako Suga; Michael T Griffin
Journal:  J Vis Exp       Date:  2011-12-26       Impact factor: 1.355

Review 2.  Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two-state and operational models.

Authors:  David Roche; Debora Gil; Jesús Giraldo
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

3.  A method for the quantification of biased signalling at constitutively active receptors.

Authors:  David A Hall; Jesús Giraldo
Journal:  Br J Pharmacol       Date:  2018-04-25       Impact factor: 8.739

Review 4.  Functional studies cast light on receptor states.

Authors:  Frederick J Ehlert
Journal:  Trends Pharmacol Sci       Date:  2015-06-26       Impact factor: 14.819

5.  Development of operational models of receptor activation including constitutive receptor activity and their use to determine the efficacy of the chemokine CCL17 at the CC chemokine receptor CCR4.

Authors:  R J Slack; D A Hall
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

6.  Estimation of the receptor-state affinity constants of ligands in functional studies using wild type and constitutively active mutant receptors: Implications for estimation of agonist bias.

Authors:  Frederick J Ehlert; Richard S L Stein
Journal:  J Pharmacol Toxicol Methods       Date:  2016-10-07       Impact factor: 1.950

7.  Estimation of ligand affinity constants for receptor states in functional studies involving the allosteric modulation of G protein-coupled receptors: implications for ligand bias.

Authors:  Frederick J Ehlert; Michael T Griffin
Journal:  J Pharmacol Toxicol Methods       Date:  2014-01-13       Impact factor: 1.950

8.  Allosteric transition: a comparison of two models.

Authors:  Niels Bindslev
Journal:  BMC Pharmacol Toxicol       Date:  2013-01-08       Impact factor: 2.483

9.  A three-parameter two-state model of receptor function that incorporates affinity, efficacy, and signal amplification.

Authors:  Peter Buchwald
Journal:  Pharmacol Res Perspect       Date:  2017-04-27

Review 10.  Community guidelines for GPCR ligand bias: IUPHAR review 32.

Authors:  Peter Kolb; Terry Kenakin; Stephen P H Alexander; Marcel Bermudez; Laura M Bohn; Christian S Breinholt; Michel Bouvier; Stephen J Hill; Evi Kostenis; Kirill A Martemyanov; Rick R Neubig; H Ongun Onaran; Sudarshan Rajagopal; Bryan L Roth; Jana Selent; Arun K Shukla; Martha E Sommer; David E Gloriam
Journal:  Br J Pharmacol       Date:  2022-03-27       Impact factor: 9.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.